科创成长层新消息：禾元生物启动发行

Core Viewpoint - Wuhan Heyuan Biotechnology Co., Ltd. has officially initiated its issuance process by disclosing its prospectus, issuance arrangements, and preliminary inquiry announcement on September 22, marking an important step in the "1+6" reform of the Sci-Tech Innovation Board [1] Group 1 - The first batch of newly registered enterprises in the Sci-Tech Growth Layer is progressing steadily, with securities companies organizing investors to sign risk disclosure agreements for participating in the trading of the Sci-Tech Growth Layer [1] - Currently, 5 million investors have opened trading permissions for the Sci-Tech Growth Layer, indicating strong market interest and participation [1] - The Shanghai Stock Exchange's technical system has completed full network testing and has begun to go live, ensuring readiness for the issuance of new registered enterprises in the Sci-Tech Growth Layer [1]